Utama › Kanser Endometrium › New Mexico › Albuquerque
Kajian klinikal Kanser Endometrium di Albuquerque, NM
12 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi dalam dan sekitar Albuquerque (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- University of New Mexico Cancer Center, Albuquerque
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Mengambil pesertaFasa 1
- University of New Mexico Cancer Center, Albuquerque
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Mengambil pesertaFasa 3
- University of New Mexico Cancer Center, Albuquerque
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Mengambil pesertaFasa 2
- University of New Mexico Cancer Center, Albuquerque
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Mengambil pesertaFasa 2
- Research Site, Albuquerque
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Mengambil pesertaFasa 3
- University of New Mexico Comprehensive Cancer Center ( Site 6046), Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Mengambil pesertaFasa 1/2
- Research Site, Albuquerque
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Mengambil pesertaFasa 3
- Research Site, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 292, Albuquerque
Uterine Preservation Via Lifestyle Transformation
Mengambil pesertaFasa 2
- University of New Mexico, Albuquerque
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Mengambil pesertaFasa 1
- University of New Mexico, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Albuquerque
Kajian Kanser Endometrium di bandar lain
- Houston, TX68 kajian
- New York City, NY52 kajian
- Boston, MA50 kajian
- Arlington, VA39 kajian
- Nashville, TN38 kajian
- Los Angeles, CA34 kajian
- St. Louis, MO29 kajian
- Philadelphia, PA28 kajian
- San Antonio, TX27 kajian
- Chicago, IL25 kajian
- Columbus, OH25 kajian
- Queens, NY25 kajian
Kajian lain di Albuquerque
- Kanser Paru-paru Bukan Sel Kecil18 kajian
- Kanser Payudara17 kajian
- Kanser Ovari15 kajian
- Kanser Paru-paru14 kajian
- Kanser (semua jenis)14 kajian
- Kanser Metastatik12 kajian
- Diabetes Jenis 211 kajian
- Penyakit Kardiovaskular10 kajian
- Kanser Prostat9 kajian
- Melanoma9 kajian
- Leukemia Mieloid Akut9 kajian
- Penyakit Buah Pinggang Kronik8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.